News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 29 set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News 10 out 2023 MSD commits to Lucerne as a business location MSD Switzerland has its sights set on further growth from its Lucerne location. Since being founded 60 years ago, the pharmaceutical company has ...
News 18 dez 2017 New conformity assessment procedure in the United Arab Emirates The new conformity assessment covers restrictions on the use of hazardous ingredients in electronic and electrical goods (RoHS: Restriction of Ha...
News 19 jun 2017 FAQ: Introduction of Value Added Tax in the United Arab Emirates Recently, the six member states of the Gulf Cooperation Council, including the United Arab Emirates (UAE), have agreed on the introduction of Val...
News 01 dez 2021 Sun Genomics sets up European subsidiary in Fribourg Probiotics specialist Sun Genomics has chosen Fribourg to set up its European subsidiary. This is the first establishment of a US company in West...
News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 13 set 2021 Incyte inaugurates its new production plant in Yverdon After establishing its European headquarters in Morges in 2020, American biopharmaceutical group Incyte strengthens its presence in the canton of...
News 30 set 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain 17 jun 2021 17 jun 2021 Suíça
News 13 abr 2021 Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp Biopharmaceutical giant Lonza has announced the creation of 1,200 new jobs for the manufacturing of Moderna’s Covid-19 vaccine on its site in Vis...
Press Release 30 jan 2024 Exports stagnant: Swiss companies adjust their expectations and strategies Swiss SMEs are still expecting minimal export growth in the coming months. This is the finding of the latest survey of Swiss SMEs conducted by Sw...